LSCGX
Price
$21.84
Change
+$0.37 (+1.72%)
Updated
Aug 6 closing price
Net Assets
133.67M
RPEBX
Price
$68.34
Change
+$0.54 (+0.80%)
Updated
Aug 6 closing price
Net Assets
156.62B
Interact to see
Advertisement

LSCGX vs RPEBX

Header iconLSCGX vs RPEBX Comparison
Open Charts LSCGX vs RPEBXBanner chart's image
Loomis Sayles Global Growth C
Price$21.84
Change+$0.37 (+1.72%)
VolumeN/A
Net Assets133.67M
American Funds New Perspective R2E
Price$68.34
Change+$0.54 (+0.80%)
VolumeN/A
Net Assets156.62B
LSCGX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LSCGX vs. RPEBX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSCGX is a Buy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 157B vs. LSCGX (134M). RPEBX pays higher dividends than LSCGX: RPEBX (0.12) vs LSCGX (0.00). LSCGX was incepted earlier than RPEBX: LSCGX (9 years) vs RPEBX (11 years). LSCGX (2.13) is less costly to investors than RPEBX (1.21). RPEBX is a more actively managed with annual turnover of: 24.00 vs. LSCGX (6.00). RPEBX has a lower initial minimum investment than LSCGX: RPEBX (250) vs LSCGX (2500). LSCGX annual gain was more profitable for investors over the last year : 33.58 vs. RPEBX (17.97). RPEBX (34.41) and LSCGX (33.17) have equivalent 5 years return.
LSCGXRPEBXLSCGX / RPEBX
Total Expense Ratio1.951.21161%
Annual Report Gross Expense Ratio2.131.21176%
Fund Existence9 years11 years-
Gain YTD13.75013.202104%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets134M157B0%
Annual Yield % from dividends0.000.12-
Returns for 1 year33.5817.97187%
Returns for 3 years54.5634.81157%
Returns for 5 years33.1734.4196%
Returns for 10 yearsN/A77.45-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TBPH11.180.09
+0.81%
Theravance Biopharma
MHH7.280.03
+0.47%
Mastech Digital
LKQ29.94-0.02
-0.07%
LKQ Corp
PRCT45.69-2.43
-5.05%
PROCEPT BioRobotics Corp
JDZG2.08-0.25
-10.73%
Jiade Limited